{"name":"TC BioPharmaceuticals","slug":"tc-bio","ticker":"TCBP","exchange":"NASDAQ","domain":"tcbiopharm.com","description":"TC BioPharmaceuticals is a biopharmaceutical company focused on developing and commercializing cell therapies for the treatment of various diseases, including cancer and autoimmune disorders. The company's pipeline includes several promising candidates, including KRYSTAL-1, a CAR-T cell therapy for the treatment of relapsed or refractory acute lymphoblastic leukemia (ALL). With a strong presence in the cell therapy and immuno-oncology markets, TCBP is well-positioned to capitalize on the growing demand for innovative cancer treatments.","hq":"Paisley, Scotland, UK","founded":0,"employees":"","ceo":"Bryan Kobel","sector":"Cell Therapy / Immuno-Oncology","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$28M","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2034-06-01","label":"KRYSTAL-1 patent cliff ($0.0B at risk)","drug":"KRYSTAL-1","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-27","type":"regulatory","headline":"TC BioPharmaceuticals Announces FDA Clearance of IND for KRYSTAL-1","summary":"TC BioPharmaceuticals announced that the FDA has cleared the Investigational New Drug (IND) application for KRYSTAL-1, a CAR-T cell therapy for the treatment of relapsed or refractory acute lymphoblastic leukemia (ALL).","drugName":"KRYSTAL-1","sentiment":"positive"},{"date":"2023-11-14","type":"earnings","headline":"TC BioPharmaceuticals Reports Third Quarter 2023 Financial Results","summary":"TC BioPharmaceuticals reported its third quarter 2023 financial results, with revenue of $10.2 million and a net loss of $23.1 million.","drugName":"","sentiment":"neutral"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQR0NkeGFRRHpuZl9uNERydEptcFpWa2l2Y0Y4OTc5eWZweW1QNEtER25TVExSeXZxTzNnTkdHbzl0b2xXUEwzNkljcmZXeXM5d2hEUXRob3RiTXM0RFFkOUVZSVRBS2dWeVFBMHpsMUpwc2VUQkFkM0JKMGdvTEdVOWtuSW9VNy1CNW5aRndHekdNSmFweWxqQXJscTBBWDZXYlFHaGpBUk1nZXpIc2c?oc=5","date":"2025-03-21","type":"pipeline","source":"Stocktwits","summary":"TC BioPharm Stock Crashes On Nasdaq Delisting: Retail Expresses Frustration - Stocktwits","headline":"TC BioPharm Stock Crashes On Nasdaq Delisting: Retail Expresses Frustration","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxORjdVRXJvbjNMbks5ZzRraHJiUF8yTzJMeDl5SnRSeFdBeDlseGpzMnVMRDU4ZFd5Z1lEakQ5RzdVQkVHUG55NXR5dGNVbG1RbHc1MFY5dWZENGY3a0hIYU9YYVhWZ0UzTnJRdkZIZkhPcXVLZ3FYcVJJMk5wZWExVHdIS04?oc=5","date":"2025-03-06","type":"deal","source":"Pharmaceutical Technology","summary":"TC BioPharm signs non-binding LoI to acquire ophthalmic company - Pharmaceutical Technology","headline":"TC BioPharm signs non-binding LoI to acquire ophthalmic company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxOQUYtRzIyWFZ3eUJCcnFHSDI3OXdKdnN1Q212bXFOV1Ytcm9PZ2VaTFdpdC1taWVaamYyemdNamxXdnJOc0c2b1NkTjBYRGtHMkxzN2NrSWQ0OEttLXpyMWs3SEVldDZ0dUU5YmctaV9jWDR1ZmpTZ0QyaWVuOGgySjJiOXNuWTVQSHo5UVJka2RZeWYtZXk5VEh4a0wwdFRBY3Z5UG0tMHpmWHpYVy1JVTZ6NWp6UTl0aEdYSmc4aWtqUTBISjd0TnBkc09xUW9OQnBRd2hHX2JRMzhOQ0tpV1NKV3VWWHdnZ05LR3B3aFYtQnpXUVRJ?oc=5","date":"2025-02-20","type":"pipeline","source":"PR Newswire","summary":"TCBP CEO Bryan Kobel to Participate on Cancer Progress Panel at 18th Annual European Life Sciences CEO Forum - PR Newswire","headline":"TCBP CEO Bryan Kobel to Participate on Cancer Progress Panel at 18th Annual European Life Sciences CEO Forum","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxNRVVzRk5SMEpLWjZNX09paU9IQl9QNnRKU01UX3o0b3Y0MUt0YloyLWRya2lGY0Q2VzRiekNWRGdaUER6bnJMRDJNMWptTnBWaDdDLUlkYXNEZy1wVF9KWXZFWjBNR0hTTXBrNVF1TllZNjd1VnBBZjZaQ20tLW5CRGx1UGk2c01SNkExRjZRT19NaTJGQ1h3UWJWLTJJSFZBckxjZjR1bjVIdzlQZjBhbnp5NkJYbUhXcVJqZmhyV1pIRGEzVlVlcg?oc=5","date":"2024-03-01","type":"pipeline","source":"PR Newswire","summary":"Bryan Kobel, CEO of TCBP, Appears on Nationally Syndicated \"The Big Biz Show\" - PR Newswire","headline":"Bryan Kobel, CEO of TCBP, Appears on Nationally Syndicated \"The Big Biz Show\"","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxOZmJKUEt0Y2NmMDB1RmpNd1gya3c2SEJwMHNwTTE1c1VUNGJJNERMQkxRTVRtX3VaY0g4X2k2V09BSEZZNDl1Z0VaZXEyMkYwYTBoMUc4ZFg0aHVTRk1wRnBlTU9JU2xybHN1eUt4UjJJMVZ3ZF9sRTZyZmQ5c0xlT2toZENwdw?oc=5","date":"2023-10-25","type":"pipeline","source":"Contract Pharma","summary":"TC BioPharm Taps Excellos as CDMO - Contract Pharma","headline":"TC BioPharm Taps Excellos as CDMO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNZzM0OG0xV2xEMTM1QWVqNVhhUE5USHkwazU0Ull1UXNBQ1FyWjNXV0ZWRzRyb2ZqTFRVUlYtVVE2LVoyTHQ5dmNXSU9FRWNoWjhtWF9ZV0FSX2ZxU3V6V3Y3OTBFbG1xQnJFVFctOENXdnhZNUhuUnBxNW1XNXNkd2xXcVVmWE1CcFVaY1hveWNkRlVmalhKWXNqbmVBSnVsRDdpNFBrRHlZU0NkQ1NCcHhOc1U?oc=5","date":"2023-02-14","type":"pipeline","source":"PR Newswire","summary":"TC BioPharm Announces New Chair of the Board, Arlene Morris - PR Newswire","headline":"TC BioPharm Announces New Chair of the Board, Arlene Morris","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxNVWR1UHRhTzFCZHl0WktLUEJfSkJCM1N1MmF1cFQxTTNUd3ZTRE1vMHA3Z3E3OU8zN0lXZkktM3hVNmUxal80UVVGVlkxbGdLYkRNbEdHYWpIVmdCbDNiQWFfQm5pemFkQUd5SmlVUzlpNkljNWozdlpZT21uTHZTMnkxYV9GcEhlbjQxa2x6ZlRqYUstVFlkdC1JR2xyVGhVSFdEYjZKaGE2ZGFnWkpBcUZ6bXBOaWVDa2MyRXBhZVBMVDR0YUxsM3NNa29DZmpDZVNCUmR1OER3SHpZeGx1VnhNOXBZRHRXRkxj?oc=5","date":"2023-01-30","type":"pipeline","source":"PR Newswire","summary":"TC BioPharm Announces Hiring of Chief Clinical Officer Bree Harlin to Lead Global Clinical Division - PR Newswire","headline":"TC BioPharm Announces Hiring of Chief Clinical Officer Bree Harlin to Lead Global Clinical Division","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9rZUxTM0JUTHF1QkpNeVYtLUNJOGQ0OXVmaVROUHVSZmJKeWlVSnNISmJ5WEFkUVdDWV9WdGlKS042OTY0WGdmTnl3Vk5PSnhhLXRpd1QwT0QydWRSUWJj?oc=5","date":"2022-04-26","type":"pipeline","source":"ChartMill","summary":"TCBP Stock Price, Quote & Chart | TC BIOPHARM HOLDINGS PLC-ADR (NASDAQ:TCBP) - ChartMill","headline":"TCBP Stock Price, Quote & Chart | TC BIOPHARM HOLDINGS PLC-ADR (NASDAQ:TCBP)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiSEFVX3lxTFBrZFNSd190MGxGam1Ca09qNVZyYV9TTFhQYXNCRzFyRTRzeExCSEMxVmc0bzRRc1dWaDgyNlE1bWRXRGhYb0RmOA?oc=5","date":"2022-03-29","type":"deal","source":"StockInvest.us","summary":"Tc Biopharm (holdings) Stock Price Forecast. Should You Buy TCBP? - StockInvest.us","headline":"Tc Biopharm (holdings) Stock Price Forecast. Should You Buy TCBP?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiTkFVX3lxTE5JQzVrVU1mR3RSYzJETlFFa0FJXzhLNWFxU3pudjVIVHVHbHp3bmJmVVluZmluc09adnExS09LLVE3elZUZFNKUnRaX1h0UQ?oc=5","date":"2022-02-11","type":"pipeline","source":"Stock Titan","summary":"Latest TCBP News - S&P Global Mobility Launches Mobility Pulse... - Stock Titan","headline":"Latest TCBP News - S&P Global Mobility Launches Mobility Pulse...","sentiment":"neutral"}],"patents":[{"drugName":"KRYSTAL-1","drugSlug":"tisotumab-vedotin","patentNumber":"","type":"Patent Cliff","expiryDate":"2034-06-01","territory":"US","annualRevenue":0}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Bristol Myers Squibb","Gilead Sciences","Novartis"],"therapeuticFocus":["Cell Therapy","Immuno-Oncology"],"financials":null,"yahoo":null}